全球碎切机市场 – 行业趋势及 2031 年预测

电动碎切机市场分析和规模

腹腔镜子宫切除术是一种切除子宫的微创手术，是分切器市场的一个重要应用。分切器用于将子宫分割成小块，这样就可以通过小切口而不是大切口将其取出。这种技术减少了手术创伤，最大限度地减少了疤痕，并缩短了患者的康复时间。由于这些好处，在腹腔镜子宫切除术中使用分切器越来越受欢迎，推动了医疗器械市场的需求。

2023 年全球碎切机市场规模价值 1.329 亿美元，预计到 2031 年将达到 2.3702 亿美元，2024 年至 2031 年预测期内的复合年增长率为 7.5%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

Market Definition

Morcellators are medical devices used during minimally invasive surgeries to cut larger tissues into smaller pieces, making them easier to remove from the body. They are commonly used in procedures such as laparoscopic hysterectomies and myomectomies to extract uterine fibroids or other growths through small incisions.

Morcellators Market Dynamics

Drivers                                                                                          

• Growing Preference for Minimally Invasive Surgeries

Patients and healthcare providers favor these procedures due to their numerous benefits, including reduced postoperative pain, shorter hospital stays, quicker recovery times, and minimal scarring. These advantages lead to increased patient satisfaction and improved surgical outcomes. As a result, there is a higher demand for advanced surgical tools such as morcellators, which facilitate these less invasive techniques, thereby propelling market growth. This trend is particularly prominent in gynecological surgeries, such as laparoscopic hysterectomy and myomectomy.

• Increasing Prevalence of Gynecological Disorders

The increasing prevalence of gynecological disorders, such as uterine fibroids and endometriosis often require surgical intervention, and the growing number of cases heightens the demand for effective treatment options. Morcellators, which facilitate minimally invasive procedures such as laparoscopic hysterectomy and myomectomy, offer a less invasive alternative to traditional open surgeries. As more women seek treatment for these disorders, the adoption of morcellators in surgical practices is expected to rise, driving market growth.

Opportunities

• Expanding Healthcare Infrastructure

As healthcare facilities improve and expand, particularly in emerging economies, there is greater access to advanced surgical procedures and technologies such as minimally invasive surgeries using morcellators. These developments enable healthcare providers to offer more sophisticated treatment options to patients suffering from conditions such as uterine fibroids and other gynecological disorders. Additionally, enhanced infrastructure supports the training of healthcare professionals in the use of morcellators, increasing their adoption and utilization in various surgical settings.

• Rising Advancements in Medical Technology

Advancements in medical technology have led to the development of safer, more precise, and efficient morcellator devices. The improvements in blade design and tissue containment systems reduce the risk of complications such as tissue dissemination and infection. Furthermore, technological advancements have enabled the integration of advanced imaging technologies, such as ultrasound and MRI, which assist surgeons in better targeting tissues for morcellation. Enhanced materials and ergonomic designs also contribute to easier handling and improved patient outcomes, encouraging healthcare providers to adopt morcellators for minimally invasive surgeries such as laparoscopic hysterectomy and myomectomy.

Restraints/Challenges

• Growing Safety Concerns

Growing safety concerns is the potential for morcellation to spread undiagnosed malignant tissue, such as uterine sarcomas, which can significantly worsen patient outcomes. This has prompted regulatory agencies to issue warnings and guidelines regarding the use of morcellators, impacting their adoption in clinical practice. Healthcare providers and patients alike are increasingly cautious due to these safety risks, leading to decreased confidence and utilization of morcellation techniques, especially in cases where malignancy cannot be definitively ruled out preoperatively.

• Stringent Regulatory Requirements

Regulatory bodies, concerned about the potential risks associated with morcellation, have implemented stringent guidelines and safety standards. These requirements often mandate thorough clinical evaluations, rigorous testing of device efficacy and safety, and strict reporting of adverse events. Compliance with these regulations can be time-consuming and costly for manufacturers, leading to delays in product approvals or market entry. Moreover, regulatory scrutiny can deter healthcare providers from adopting morcellators, particularly in regions where concerns over safety and efficacy are heightened.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• 2019 年 9 月，美敦力在美国推出了 Evolut PRO+ 经导管主动脉瓣置换术 (TAVR) 系统。TAVR 是一种微创手术，用于治疗传统开胸心脏手术风险较高的患者的严重主动脉瓣狭窄。Evolut PRO+ 系统在前几代产品的基础上进行了改进，旨在改善瓣膜性能和患者预后，为患有严重主动脉瓣疾病的患者扩大治疗选择
• 2019 年 9 月，雅培启动了其 TriClip 经导管三尖瓣修复系统的 TRILUMINATE 关键试验。该系统旨在解决三尖瓣反流，即由于三尖瓣关闭不当导致血液回流到右心房的情况。TriClip 手术旨在减少反流并改善心脏功能，而无需进行开胸手术，为患有这种具有挑战性的瓣膜疾病的患者提供一种侵入性较小的治疗选择

电动碎切机市场范围

市场根据类型、应用、使用类型和最终用途进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品类型

• 电动碎切器
  • 宫腔镜分切器
  • 腹腔镜分切器
• 手动碎切器
• 其他的

 使用类型

• 可重复使用的
• 可重复利用
• 一次性的

应用

• 子宫肌瘤
• 宫腔镜检查
• 腹腔镜检查
• 其他的

 最终用途

• 医院
• 门诊手术中心
• 专科诊所
• 其他的

电动碎切机市场区域分析/见解

对市场进行分析，并按上述国家、类型、应用、使用类型和最终用途提供市场规模洞察和趋势。

市场报告涉及的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区其他地区 (APAC)、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区 (MEA)、巴西、阿根廷和南美洲其他地区。

北美在市场上占据主导地位，这归功于其强大的医疗基础设施和腹腔镜技术的重大进步。这些因素确保了高质量的医疗服务和创新手术工具的广泛采用。此外，对医疗保健的大力投资和对微创手术的关注进一步巩固了该地区在该市场的领先地位。

由于民众健康意识的增强和对先进医疗技术的需求不断增长，预计亚太地区将实现最高的市场增长率。随着人们越来越关注自己的健康，人们更加重视采用创新的医疗解决方案，从而推动该地区的市场增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和电动碎切机市场分析

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• BLUE ENDO（美国）
• 卡尔·史托斯（德国）
• Richard Wolf GmbH（德国）
• 富兰克林邓普顿。（美国）
• Lumenis Be Limited（以色列）
• Hologic Inc.（美国）
• Smith+Nephew（美国）
• 奥林巴斯株式会社（日本）
• Nouvag（德国）
• LiNA Medical ApS（丹麦）
• 美敦力（爱尔兰）
• 史赛克（美国）
• 库克（美国）
• BD（美国）

SKU-53282